Leadman: Progress announcement on the use of idle own funds for delegated financial management
Leadman: Announcement on completing the registration of the legal representative\'s trade change
Leadman: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Leadman: Legal Opinion of the 2024 First Extraordinary General Meeting of Shareholders
Leadman: Announcement on the completion and election of the chairman, chairman of the board of supervisors, board special committee members, and the appointment of senior managers, representatives of securities affairs, and heads of internal audit departments
Leadman: Prompt Announcement on Convening the 2024 First Extraordinary General Meeting of Shareholders
Leadman: Announcement on the election of the company\'s board of directors for a new term
Leadman: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Leadman: Announcement on the election of the company\'s board of supervisors for a new term
Leadman: Announcement on the Election of Staff Representative Supervisors for the 6th Board of Supervisors
Leadman: An indicative announcement on the disclosure of the 2024 third quarter report
Leadman: Progress announcement on the use of idle own funds for delegated financial management
Leadman: Progress announcement on the use of idle own funds for delegated financial management
Leadman: Announcement on the acquisition of a medical device registration certificate by its subsidiary Desai Systems
Beijing Leadman Biochemistry: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Beijing Leadman Biochemistry: Interim report disclosure prompt announcement for 2024.
Beijing Leadman Biochemistry: Announcement Regarding Write-Back of Asset Impairment Provision in the First Half of 2024.
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds
Beijing Leadman Biochemistry: Announcement on the Progress of Overseas Investment.
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds